Vident Investment Advisory’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-53,106
| Closed | -$18.7M | – | 1051 |
|
|
2023
Q2 | $18.7M | Sell |
53,106
-4,471
| -8% | -$1.57M | 0.64% | 21 |
|
|
2023
Q1 | $18.1M | Buy |
57,577
+4,325
| +8% | +$1.36M | 0.59% | 21 |
|
|
2022
Q4 | $15.4M | Buy |
53,252
+21,209
| +66% | +$6.12M | 0.58% | 29 |
|
|
2022
Q3 | $8.98M | Sell |
32,043
-4,234
| -12% | -$1.19M | 0.29% | 79 |
|
|
2022
Q2 | $10.2M | Sell |
36,277
-5,177
| -12% | -$1.46M | 0.31% | 71 |
|
|
2022
Q1 | $10.8M | Buy |
41,454
+11,330
| +38% | +$2.96M | 0.28% | 75 |
|
|
2021
Q4 | $6.62M | Buy |
30,124
+9,645
| +47% | +$2.12M | 0.17% | 133 |
|
|
2021
Q3 | $3.72M | Buy |
20,479
+17,423
| +570% | +$3.16M | 0.11% | 182 |
|
|
2021
Q2 | $616K | Sell |
3,056
-700
| -19% | -$141K | 0.02% | 785 |
|
|
2021
Q1 | $808K | Buy |
3,756
+1,552
| +70% | +$334K | 0.03% | 674 |
|
|
2020
Q4 | $521K | Buy |
2,204
+173
| +9% | +$40.9K | 0.02% | 701 |
|
|
2020
Q3 | $553K | Sell |
2,031
-1,191
| -37% | -$324K | 0.03% | 639 |
|
|
2020
Q2 | $935K | Buy |
+3,222
| New | +$935K | 0.05% | 500 |
|
|
2018
Q2 | – | Sell |
-1,380
| Closed | -$219K | – | 976 |
|
|
2018
Q1 | $219K | Buy |
+1,380
| New | +$219K | 0.01% | 842 |
|
|
2015
Q3 | – | Sell |
-50
| Closed | -$6K | – | 1157 |
|
|
2015
Q2 | $6K | Buy |
+50
| New | +$6K | ﹤0.01% | 1003 |
|